Literature DB >> 20519677

Identifying and eliminating the roadblocks to comparative-effectiveness research.

Daniel F Martin1, Maureen G Maguire, Stuart L Fine.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20519677     DOI: 10.1056/NEJMp1001201

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Translating comparative effectiveness research into clinical practice: the UK experience.

Authors:  Tom Walley
Journal:  Drugs       Date:  2012-01-22       Impact factor: 9.546

2.  Perspectives on comparative effectiveness research: views from diverse constituencies.

Authors:  Dave Nellesen; Howard G Birnbaum; Paul E Greenberg
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  Surgeon volume is associated with cost and variation in surgical treatment of proximal humeral fractures.

Authors:  Nitin B Jain; Ifedayo Kuye; Laurence D Higgins; Jon J P Warner
Journal:  Clin Orthop Relat Res       Date:  2012-07-24       Impact factor: 4.176

4.  Serious Adverse Events with Bevacizumab or Ranibizumab for Age-related Macular Degeneration: Meta-analysis of Individual Patient Data.

Authors: 
Journal:  Ophthalmol Retina       Date:  2017-04-12

5.  Therapeutic efficacy of bevacizumab for age-related macular degeneration: what are the implications of CATT for routine management?

Authors:  Focke Ziemssen; Bianka Sobolewska
Journal:  Drugs Aging       Date:  2011-11-01       Impact factor: 3.923

6.  The pragmatist's guide to comparative effectiveness research.

Authors:  Amitabh Chandra; Anupam B Jena; Jonathan S Skinner
Journal:  J Econ Perspect       Date:  2011

7.  Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials.

Authors:  Janet T Holbrook; John H Kempen; Nancy A Prusakowski; Michael M Altaweel; Douglas A Jabs
Journal:  Clin Trials       Date:  2011-10-12       Impact factor: 2.486

8.  Cyberinfrastructure and the biomedical sciences.

Authors:  Bradford W Hesse; Robert T Croyle; Kenneth H Buetow
Journal:  Am J Prev Med       Date:  2011-05       Impact factor: 5.043

9.  Ranibizumab and bevacizumab for neovascular age-related macular degeneration.

Authors:  Daniel F Martin; Maureen G Maguire; Gui-shuang Ying; Juan E Grunwald; Stuart L Fine; Glenn J Jaffe
Journal:  N Engl J Med       Date:  2011-04-28       Impact factor: 91.245

10.  Evolution of Intravitreal Therapy for Retinal Diseases-From CMV to CNV: The LXXIV Edward Jackson Memorial Lecture.

Authors:  Daniel F Martin
Journal:  Am J Ophthalmol       Date:  2018-01-12       Impact factor: 5.258

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.